Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 2Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hematologic Neoplasms 4Glioma 3Multiple Myeloma 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Smoking Cessation 1Sarcoma 1Osteosarcoma 1Neoplasms 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Medulloblastoma 1Lung Neoplasms 1Hypogonadism 1Hematopoietic and Lymphatic System Neoplasm 1Heart Failure 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Colonic Neoplasms 1Colitis 1Central Nervous System Neoplasms 1Cardiomyopathies 1Carcinoma, Non-Small-Cell Lung 1Anemia, Aplastic 1

Interventions

Oxaliplatin 31Fluorouracil 31Leucovorin 29Irinotecan 23Cetuximab 20Bevacizumab 16Capecitabine 13Gemcitabine 11pembrolizumab 8Folfox protocol 7Cisplatin 7Carboplatin 7Paclitaxel 6Nivolumab 6Cyclophosphamide 6trifluridine tipiracil drug combination 5cediranib 5Erlotinib Hydrochloride 5adagrasib 4Ipilimumab 4IFL protocol 4Floxuridine 4Bortezomib 4veliparib 3trametinib 3sargramostim 3poly ICLC 3binimetinib 3Trifluridine 3Sorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Colonic Neoplasms × Standard of Care × Clear all
NCT01200316 2017-11-30

Rocking Motion: Physiologic Effect on the Surgical Stress Response

M.D. Anderson Cancer Center

Phase 1 Completed
86 enrolled
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡